| Join biopharmaceutical and biotechnology industry upcoming 7th Bioassay Workshop. Presentations, case studies, and breakout sessions will cover topics including: |
- The latest methods in bioassay development and management
- Cutting edge software development for bioassay data analysis
- Current FDA views on bioassay lifecycle management
- Bioassay qualification
- Equivalence testing for dilutional similarity
|
|
| |
| Hear from Bioassay Experts Including: |
| |
Robert Singer, Robert Singer Consulting
Chair, USP General Chapters-Statistics Expert Committee
|
| |
 |
| |
Alfred V. Del Grosso, Ph.D., FDA-CBER-OCBQ
FDA Perspective on Stage 3, Continued
Procedure Performance Verification
|
| |
 |
| |
Richard Burdick, Ph.D., Chief Statistician,
Member, USP General Chapters - Statistics
Expert Committee
Current Thoughts on Statistical Tools for
Procedure Validation |
| |
 |
|
|
| Confirm your Seat! |
| |
 |
| |
| Group Discounts Available! |
| |
|
| |
| Who Should Participate? |
| |
- Biopharmaceutical/biotechnology industry professionals
- Biopharmaceutical development scientists
- Pharmaceutical industry professionals
- Regulatory experts for biologics
- Biosimilar manufacturers
- Bioassay practitioners and software experts
- Biostatisticians
- Analytical development scientists
- QA/QC specialists for biologics
|
| |
| Agenda: |
| |
- Click here to view full Agenda
|
|
| |
Questions:
Email: conferences@usp.org
Phone: +1 301-816-8130
Website: Bioassay Workshop |
|
